Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.
Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.PEP and Carlyle bought iNova in 2017 from US giant Valeant Pharmaceuticals.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Sources said TPG had emerged from the auction as the most likely buyer after owners Pacific Equity Partners and The Carlyle Group took binding bids on Friday.
The business is expected to be worth more than $2 billion.TPG Capital was one of three known bidders – the others were its global PE rivals Blackstone and Bain Capital.
Sources said the talks to sign a deal were well advanced on Tuesday morning.
Source: Headtopics
Can’t stop reading? Read more
Quadrivio Group acquires majority stake in Les Secrets de Loly through Made in Italy Fund II
Quadrivio Group acquires majority stake in Les Secrets de Loly through Made in Italy Fund II...
Warburg Pincus explores sale or partnership for Southeast Asian insurer Oona
Warburg Pincus explores sale or partnership for Southeast Asian insurer Oona Warburg Pincus is...
I Squared Capital nears $10bn for flagship infrastructure fund amid sector boom
I Squared Capital nears $10bn for flagship infrastructure fund amid sector boom I Squared Capital...